Is nedocromil sodium effective treatment for asthma?
نویسندگان
چکیده
In the past decade, the Lreaune nt of usLhma has changed. This evolution occurred with the realization that prevention of regular asthma symptoms is preferable to treatme nt of asthmatic symptoms when they develop. Thi s unders tanding is reflected in the consensus reports on asthma management , which have rece ntly been publi shed in several countries ll-41 . These reports agree that the main aim of management is to keep asthmatic patients functioning as c lose to normal. f()r as muc h of the rime, as possible. With this in mind, the currently available drugs to treat asthma, for practical purposes, fall into two classes: those which are most useful to treat symptoms when they develop (such as P 2 -agonists or theophylline), and those which are most useful in preventing regular sympLOms and exaccrbat ions of asthma from occ uring (suc h as inhaled corticos te roids or cromoglycate). Whilst this division is somewhat artificial, (for example, inhaled P2-agonists are very useful for preventing exerc iseinduced bronc hoconsLriction) . the distinction between these c lasses of drugs IHL~ practical importance, as inhal ed corticosteroids or c rorn-oglycate arc now recomme nded as the most appropriate regular maintenance treatment for asthmatic patients witb anything o ther than infrequent symptoms [1-4]. A recent addition to the physicians therapeutic armament for asthma treatment is nedocromil sodium, which was originally developed as an agent which would inhibit the release of mediators from inflammatory cells present in the airways of all (even mild, stable) asthmatics. The drug was developed as an extension of cromolyn, which was thought at the time to have similar pharmacological properties. It was hoped that nedocromil would have significant therapeutic advantages, but would retain the low side-effect profile of cromolyn. Nedocromil has been extensively studied in asthma, and the results of all known published and unpublished, placebo-controlled, double-blind, randomized clinical trials have been incorporated into a metaanalysis by EowARDS and STEVENS [5]. These authors are associated with the company which has developed and marketed nedocromil and, thereby, have access to all available clinical trials, including unpublished data,
منابع مشابه
Double blind, placebo controlled study of nedocromil sodium in asthma.
After a two week baseline, 209 asthmatic children (mean age 10 years, range 6-17) were randomly allocated to receive 4 mg nedocromil sodium (n = 110) or placebo (n = 99) four times daily for 12 weeks in addition to their current treatment. The children completed daily diary cards and visited the clinic at four week intervals. Statistically significant differences in favour of nedocromil sodium ...
متن کاملTreatment of nocturnal asthma with nedocromil sodium.
BACKGROUND The association of nocturnal asthma symptoms with a diurnal increase in inflammatory activity suggests a role for anti-inflammatory therapy in nocturnal asthma. METHODS Fifty patients with asthma with nocturnal symptoms entered a randomised, double blind, placebo controlled, crossover study. After a two week baseline period patients received nedocromil sodium (4 mg) or placebo four...
متن کاملInhaled nedocromil sodium as additional treatment to high dose inhaled corticosteroids in the management of bronchial asthma.
Thirty five asthmatic patients were included in a randomized, double-blind, placebo-controlled, parallel group study of inhaled nedocromil sodium (4 x 4 mg daily) as an additional treatment to high dose (greater than or equal to 1,000 micrograms) inhaled corticosteroids in the management of bronchial asthma. Following a four week baseline, patients received nedocromil sodium (17) or placebo tre...
متن کاملQuality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial
Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. P.W. Jones and the Nedocromil Sodium Quality of Life Study Group. ERS Journals Ltd 1994. ABSTRACT: This study was designed to measure improvement in quality of life of patients with asthma, using a standardized disease-specific questionnaire, the St...
متن کاملEvidence-based asthma management.
In 2002 the National Asthma Education and Prevention Program published evidence-based guidelines for the diagnosis and management of asthma, but there are some unresolved asthma-management issues that need further research. For asthmatic children inhaled corticosteroids are more beneficial than as-needed use of beta(2) agonists, long-acting beta(2) agonists, theophylline, cromolyn sodium, nedoc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The European respiratory journal
دوره 6 1 شماره
صفحات -
تاریخ انتشار 1993